49 results on '"Kitazato, Kenji"'
Search Results
2. Task shifting in university education in the field of clinical examination
3. Novel iontophoretic administration method for local therapy of breast cancer
4. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer
5. Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity
6. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs
7. A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma
8. Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model
9. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide GaINAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma
10. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation
11. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: Potential new therapy for ovarian clear cell adenocarcinoma
12. Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent Transcription
13. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model
14. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells
15. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model
16. An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA
17. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor
18. Both N- and C-terminal transactivation functions of DNA-bound ERα are blocked by a novel synthetic estrogen ligand
19. Prognostic significance of UDP‐N‐acetyl‐α‐D‐galactosamine:polypeptide N‐acetylgalactosaminyltransferase‐3 (GalNAc‐T3) expression in patients with gastric carcinoma
20. Expression of UDP-N-acetyl-α-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma
21. Analysis ofHelicobacter pyloribinding site on HEp-2 cells and three cell lines from human gastric carcinoma
22. The Anticoagulant and Hemorrhagic Effects of DHG, a New Depolymerized Holothurian Glycosaminoglycan, on Experimental Hemodialysis in Dogs
23. Neutralization of DHG, a New Depolymerized Holothurian Glycosaminoglycan, by Protamine Sulfate and Platelet Factor 4
24. Antithrombin III-Independent Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Acute Thromboembolism in Mice
25. Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Tissue Factor Pathway Inhibitor: In Vitro and In Vivo Studies
26. DHG, A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN, EXERTS AN ANTITHROMBOTIC EFFECT WITH LESS BLEEDING THAN UNFRACTIONATED OR LOW MOLECULAR WEIGHT HEPARIN, IN RATS
27. INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA
28. Alteration of energy substrates utilized by small and large thymocytes in resting and stimulating state
29. Arginine-Enriched Solution Induces a Marked Increase in Muscle Glutamine Concentration and Enhances Muscle Protein Synthesis in Tumor-Bearing Rats
30. Effect of Arginine-Enriched Total Parenteral Nutrition on the Host-Tumor Interaction in Cancer-Bearing Rats
31. Antithrombotic and Anticoagulant Activity of Depolymerized Fragment of the Glycosaminoglycan Extracted from Stichopus japonicus Selenka
32. Effect of propiverine hydrochloride on the function of the bladder in decerebrated dogs.
33. Analysis of Helicobacter pylori binding site on HEp-2 cells and three cell lines from human gastric carcinoma.
34. Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin.
35. Expression of UDP-N-acetyl-α-D-galactosaminepolypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma
36. Analysis of Helicobacter pyloribinding site on HEp‐2 cells and three cell lines from human gastric carcinoma
37. Neutralization of DHG, a New Depolymerized Holothurian Glycosaminoglycan, by Protamine Sulfate and Platelet Factor 4
38. Mode of inhibitory action of propiverine hydrochloride on the micturition movements of the bladder in dogs.
39. Effects of propiverine hydrochloride(P-4) on urinary bladder functions of the dog
40. Antitumor activities of harringtonine and homoharringtonine, cephalotaxus alkaloids which are active principles from plant by intraperitoneal and oral administration.
41. Effect of propiverine hydrochloride on the function of the bladder in dogs.
42. Effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide, a new antitumor agent with inorganic ring, on various experimental tumors.
43. Depolymerized Holothurian Glycosaminoglycan With Novel Anticoagulant Actions: Antithrombin III- and Heparin Cofactor II-Independent Inhibition of Factor X Activation by Factor IXa-Factor Villa Complex and Heparin Cofactor H-Dependent Inhibition of Thrombin
44. O-167 - Effects of propiverine hydrochloride(P-4) on urinary bladder functions of the dog
45. Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
46. A novel anticancer ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells.
47. Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
48. [The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
49. [Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.